Synthesis, antimicrobial activity and Molecular docking study of some novel isoxazole incorporated benzimidazole derivatives

Authors

  • Pankaj Kumar Sharma Department of Pharmaceutical Chemistry, Bhupal Nobles’ College of Pharmacy, Bhupal Nobles’ University, Udaipur, Rajasthan, India
  • Chandra Shekhar Sharma Department of Pharmaceutical Chemistry, Bhupal Nobles’ College of Pharmacy, Bhupal Nobles’ University, Udaipur, Rajasthan, India

Abstract

A series of novel isoxazole-incorporated benzimidazole derivatives was synthesized and investigated for antimicrobial activity. The structures of all synthesized compounds were confirmed by means of elemental analysis, infrared spectroscopy (IR), proton nuclear magnetic resonance (1H-NMR), and liquid chromatography-mass spectrometry (LC-MS). All compounds were evaluated for antimicrobial activity cup plate method against Staphylococcus aureus, Bacillus anthracis, Pseudomonas aeruginosa, Escherchia coli, Candida albicans and Aspegillus niger. The 4d, 4f and 4j compounds showed significant activity against gram-positive and gram-negative bacteria. On the basis of the interaction energy criterion, compound 4f showed the best docking interactions equal to 7.0 kcal/mol.

Keywords:

isoxazole, benzimidazole, antimicrobial activity, synthesis, molecular docking

DOI

https://doi.org/10.25004/IJPSDR.2023.150601

References

Croft AC, D Antoni AV, Terzulli SL. Update on the antibacterial resistance crisis. Medical science monitor. 2007; 13(6): RA103.

Cervera C, Van Delden C, Gavaldà J, Welte T, Akova M, Carratalà J, ESCMID Study Group for Infections in Compromised Hosts (ESGICH). Multidrug‐resistant bacteria in solid organ transplant recipients. Clinical Microbiology and Infection. 2014; 20: 49-73.

Keelara S, Scott HM, Morrow WM, Gebreyes WA, Correa M, Nayak R, Stefanova R, Thakur S. Longitudinal study of distributions of similar antimicrobial-resistant Salmonella serovars in pigs and their environment in two distinct swine production systems. Applied and environmental microbiology. 2013; 79(17): 5167-5178.

Sharma J, Kumar D, Hussain S, Pathak A, Shukla M, Kumar VP, Anisha PN, Rautela R, Upadhyay AK, Singh SP. Prevalence, antimicrobial resistance and virulence genes characterization of nontyphoidal Salmonella isolated from retail chicken meat shops in Northern India. Food control. 2019; 102: 104-111.

Basak S, Rajurkar MN, Mallick SK, Attal RO. Infection control practices in health care set-up. Infection Control. 2013; 1: 67-69.

Strockbine NA, Bopp CA, Fields PI, Kaper JB, Nataro JP. Escherichia, Shigella, and Salmonella. Manual of clinical microbiology. 2015: 685-713.

Fishman JA. Infection in organ transplantation. American Journal of Transplantation. 2017 Apr;17(4):856-879.

Htwe TH, Mushtaq A, Robinson SB, Rosher RB, Khardori N. Infection in the elderly. Infectious disease clinics of North America. 2007; 21(3): 711-743.

Moreau SJ. “It stings a bit but it cleans well”: venoms of Hymenoptera and their antimicrobial potential. Journal of insect physiology. 2013; 59(2): 186-204.

Chambers HF. General principles of antimicrobial therapy. Goodman Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, USA. 2006: 1095-1111.

Bodey GP. Infection in cancer patients: a continuing association. The American journal of medicine. 1986; 81(1): 11-26.

Sardi JC, Almeida AM, Giannini MJ. New antimicrobial therapies used against fungi present in subgingival sites—a brief review. Archives of oral biology. 2011; 56(10): 951-959.

Jawetz E. Antimicrobial chemotherapy. Annual Review of Microbiology. 1956; 10(1): 85-114.

Maisch T, Szeimies RM, Jori G, Abels C. Antibacterial photodynamic therapy in dermatology. Photochemical & Photobiological Sciences. 2004; 3(10): 907-917.

Yolton DP, Haesaert SP. Antiinfective drugs. Clinical ocular pharmacology. 2001; 11: 219-264.

Weledji EP, Weledji EK, Assob JC, Nsagha DS. Pros, cons and future of antibiotics. New Horizons in Translational Medicine. 2017; 4(1-4): 9-14.

Bochud PY, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Critical care medicine. 2004; 32(11): S495-S512.

Levy SB. Factors impacting on the problem of antibiotic resistance. Journal of Antimicrobial Chemotherapy. 2002; 49(1): 25-30.

Nuti R, Goud NS, Saraswati AP, Alvala R, Alvala M. Antimicrobial peptides: a promising therapeutic strategy in tackling antimicrobial resistance. Current medicinal chemistry. 2017; 24(38): 4303-4314.

Wright GD. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends in microbiology. 2016; 24(11): 862-871.

Cromwell GL. Antimicrobial agents. Swine nutrition. 1991: 297-314.

Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacological reviews. 2003; 55(1): 27-55.

Medina E, Pieper DH. Tackling threats and future problems of multidrug-resistant bacteria. How to overcome the antibiotic crisis. 2016: 3-3.

Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence. 2013; 4(2): 185-191.

Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AP, Nautiyal AR. Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials—a review. Plants. 2017; 6(2): 16.

Ahmed OS, Tardif C, Rouger C, Atanasova V, Richard‐Forget F, Waffo‐Téguo P. Naturally occurring phenolic compounds as promising antimycotoxin agents: Where are we now?. Comprehensive Reviews in Food Science and Food Safety. 2022; 21(2): 1161-1197.

Bajpai VK, Rahman A, Kang SC. Chemical composition and inhibitory parameters of essential oil and extracts of Nandina domestica Thunb. to control food-borne pathogenic and spoilage bacteria. International Journal of Food Microbiology. 2008; 125(2): 117-122.

Mulat M, Pandita A, Khan F. Medicinal plant compounds for combating the multi-drug resistant pathogenic bacteria: a review. Current pharmaceutical biotechnology. 2019; 20(3): 183-196.

Shin J, Prabhakaran VS, Kim KS. The multi-faceted potential of plant-derived metabolites as antimicrobial agents against multidrug-resistant pathogens. Microbial pathogenesis. 2018; 116: 209-214.

Rathod NB, Kulawik P, Ozogul F, Regenstein JM, Ozogul Y. Biological activity of plant-based carvacrol and thymol and their impact on human health and food quality. Trends in Food Science & Technology. 2021; 116: 733-748.

Ju J, Xie Y, Yu H, Guo Y, Cheng Y, Qian H, Yao W. Synergistic interactions of plant essential oils with antimicrobial agents: a new antimicrobial therapy. Critical Reviews in Food Science and Nutrition. 2022; 62(7): 1740-1751.

Górniak I, Bartoszewski R, Króliczewski J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochemistry Reviews. 2019; 18(1): 241-272.

Omojate Godstime C, Enwa Felix O, Jewo Augustina O, Eze Christopher O. Mechanisms of antimicrobial actions of phytochemicals against enteric pathogens–a review. J Pharm Chem Biol Sci. 2014; 2(2): 77-85.

Jung SY, Lee SH, Lee SY, Yang S, Noh H, Chung EK, Lee JI. Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis. Critical Care. 2017; 21(1): 1-5.

Ament PW, Jamshed N, Horne JP. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections. American family physician. 2002; 65(4):663-671.

Rawson TM, Ming D, Ahmad R, Moore LS, Holmes AH. Antimicrobial use, drug-resistant infections and COVID-19. Nature Reviews Microbiology. 2020; 18(8): 409-10.

de la Fuente-Nunez C, Torres MD, Mojica FJ, Lu TK. Next-generation precision antimicrobials: towards personalized treatment of infectious diseases. Current opinion in microbiology. 2017; 37: 95-102.

van Eijk E, Wittekoek B, Kuijper EJ, Smits WK. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. Journal of Antimicrobial Chemotherapy. 2017; 72(5): 1275-84.

Schwartz KL, Morris SK. Travel and the spread of drug-resistant bacteria. Current infectious disease reports. 2018; 20(9): 29.

Gill EE, Franco OL, Hancock RE. Antibiotic adjuvants: diverse strategies for controlling drug‐resistant pathogens. Chemical biology & drug design. 2015; 85(1): 56-78.

Galenko AV, Khlebnikov AF, Novikov MS, Pakalnis VV, Rostovskii NV. Recent advances in isoxazole chemistry. Russian Chemical Reviews. 2015; 84(4): 335.

Spasov AA, Yozhitsa IN, Bugaeva LI, Anisimova VA. Benzimidazole derivatives: Spectrum of pharmacological activity and toxicological properties (A Review). Pharmaceutical Chemistry Journal. 1999; 33(5): 232-243.

Eddington ND, Cox DS, Roberts RR, Butcher RJ, Edafiogho IO, Stables JP, Cooke N, Goodwin AM, Smith CA, Scott KR. Synthesis and anticonvulsant activity of enaminones.: 4. Investigations on isoxazole derivatives. European Journal of Medicinal Chemistry. 2002; 37(8): 635-648.

Shingalapur RV, Hosamani KM, Keri RS, Hugar MH. Derivatives of benzimidazole pharmacophore: Synthesis, anticonvulsant, antidiabetic and DNA cleavage studies. European Journal of Medicinal Chemistry. 2010; 45(5): 1753-1759.

Kumar, J., Akhtar, M., Ranjan, C., & Chawla, G. (2015). Design, synthesis and neuropharmacological evaluation of thiophene incorporated isoxazole derivatives as antidepressant and antianxiety agents. International Journal of Pharmaceutical Chemistry and Analysis, 14, 274-283.

Tantray MA, Khan I, Hamid H, Alam MS, Dhulap A, Kalam A. Synthesis of benzimidazole-linked-1, 3, 4-oxadiazole carboxamides as GSK-3β inhibitors with in vivo antidepressant activity. Bioorganic Chemistry. 2018; 77: 393-401.

Mao J, Yuan H, Wang Y, Wan B, Pak D, He R, Franzblau SG. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs. Bioorganic & Medicinal Chemistry Letters. 2010; 20(3): 1263-1268.

Keng Yoon Y, Ashraf Ali M, Choon TS, Ismail R, Chee Wei A, Suresh Kumar R, Osman H, Beevi F. Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives. BioMed research international. 2013.

Mączyński M, Artym J, Kocięba M, Kochanowska I, Ryng S, Zimecki M. Anti-inflammatory properties of an isoxazole derivative—MZO-2. Pharmacological Reports. 2016; 68(5): 894-902.

Veerasamy R, Roy A, Karunakaran R, Rajak H. Structure–activity relationship analysis of benzimidazoles as emerging anti-inflammatory agents: An overview. Pharmaceuticals. 2021; 14(7): 663.

Arjmand F, Mohani B, Ahmad S. Synthesis, antibacterial, antifungal activity and interaction of CT-DNA with a new benzimidazole derived Cu (II) complex. European Journal of Medicinal Chemistry. 2005; 40(11): 1103-1110.

Kang YK, Shin KJ, Yoo KH, Seo KJ, Hong CY, Lee CS, Park SY, Kim DJ, Park SW. Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety. Bioorganic & medicinal chemistry letters. 2000; 10(2): 95-99.

Yang Z, Li P, Gan X. Novel pyrazole-hydrazone derivatives containing an isoxazole moiety: Design, synthesis, and antiviral activity. Molecules. 2018; 23(7): 1798.

Sharma D, Narasimhan B, Kumar P, Judge V, Narang R, De Clercq E, Balzarini J. Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles. Journal of enzyme inhibition and medicinal chemistry. 2009 Oct 1;24(5):1161-1168.

Hisano T, Ichikawa M, Tsumoto K, Tasaki M. Synthesis of benzoxazoles, benzothiazoles and benzimidazoles and evaluation of their antifungal, insecticidal and herbicidal activities. Chemical and Pharmaceutical Bulletin. 1982; 30(8): 2996-3004.

Xie F, Ni T, Ding Z, Hao Y, Wang R, Wang R, Wang T, Chai X, Yu S, Jin Y, Jiang Y. Design, synthesis, and in vitro evaluation of novel triazole analogues featuring isoxazole moieties as antifungal agents. Bioorganic Chemistry. 2020; 101: 103982.

Arya GC, Kaur K, Jaitak V. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies. European Journal of Medicinal Chemistry. 2021; 221: 113511.

Cheong JE, Zaffagni M, Chung I, Xu Y, Wang Y, Jernigan FE, Zetter BR, Sun L. Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry. 2018; 144: 372-85.

Pallas 3.1.1.2, ADME-Tox software, CompuDrug International Inc., U.S.A., 2000

http://www.molinspiration.com/cgi-bin/properties (Retrieved on 11/5/2020)

Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharmaceutical research. 2002; 19(10): 1446-1457.

Trott O, Olson AJ. Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function. Efficient Optimization, and Multithreading. 2010; 31(2): 455-461.

O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J Cheminform. 2011; 3: 33.

Alegaon SG, Alagawadi KR, Kumar D, Kavalapure RS, Ranade SD, Priya AS, Jalalpure SS. Synthesis, molecular docking and ADME studies of thiazole-thiazolidinedione hybrids as antimicrobial agents. Journal of Biomolecular Structure and Dynamics. 2021; 1-7.

Moorthy NSHN, Singh RJ, Singh HP, Gupta SD. Synthesis, biological evaluation and in silico metabolic and toxicity prediction of some flavanone derivatives. Chemical and Pharmaceutical Bulletin, 2006; 54(10): 1384-1390.

Published

30-11-2023
Statistics
Abstract Display: 704
PDF Downloads: 1159
Dimension Badge

How to Cite

“Synthesis, Antimicrobial Activity and Molecular Docking Study of Some Novel Isoxazole Incorporated Benzimidazole Derivatives”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 15, no. 6, Nov. 2023, pp. 680-7, https://doi.org/10.25004/IJPSDR.2023.150601.

Issue

Section

Research Article

How to Cite

“Synthesis, Antimicrobial Activity and Molecular Docking Study of Some Novel Isoxazole Incorporated Benzimidazole Derivatives”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 15, no. 6, Nov. 2023, pp. 680-7, https://doi.org/10.25004/IJPSDR.2023.150601.

Similar Articles

1-10 of 564

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)